IGC Pharma, Inc. — Director's Dealing 2017

Dec 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2017-12-04

Reporting Person: PRINS RICHARD K (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-04	Common Stock	S	30	$0.56	Disposed	438970	Direct
2017-12-04	Common Stock	S	1200	$0.56	Disposed	437770	Direct
2017-12-04	Common Stock	S	600	$0.56	Disposed	437170	Direct
2017-12-04	Common Stock	S	100	$0.55	Disposed	437070	Direct
2017-12-04	Common Stock	S	500	$0.55	Disposed	436570	Direct
2017-12-04	Common Stock	S	100	$0.55	Disposed	436470	Direct
2017-12-04	Common Stock	S	22470	$0.55	Disposed	414000	Direct